Systemic effects of cystic fibrosis transmembrane conductance regulator modulators on the plasma and serum proteome
Cell Systems · 2026
DOI: 10.1016/j.cels.2026.101569 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Systems, 2026. Verfasst von Kerstin Fentker und 14 weiteren Autor:innen. Beteiligte Einrichtung: Proteomics Platform, Max Delbrück Center for Molecular Medicine, Berlin, Germany; Institute for Chemistry and Biochemistry, Freie Universität Berlin,…. Hauptthemen laut MEDLINE: Cystic Fibrosis Transmembrane Conductance Regulator, Cystic Fibrosis, Proteome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation, Federal Ministry of Education and Research Bonn Office.
Abstract (Originalsprache)
Cystic fibrosis (CF) is caused by dysfunction of the cystic fibrosis transmembrane conductance regulator (CFTR) anion channel in epithelial organs leading to a complex multi-organ disease. CFTR modulator drugs improve mutant CFTR function and markedly improve clinical outcomes in people with CF (pwCF), but their broader molecular and systemic effects remain to be fully elucidated. We employed mass-spectrometry-based proteomics to compare the plasma and serum proteomes of pwCF treated with the dual combination CFTR modulator lumacaftor/ivacaftor (LUM/IVA) or the triple combination of elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA). We found specific and common signatures associated with inflammation and metabolic processes. ELX/TEZ/IVA showed more consistent effects that were directed toward profiles in healthy individuals. Our findings indicate that ELX/TEZ/IVA leads to broader improvements in protein dysregulation than LUM/IVA in pwCF. Residual proteome changes may inform future therapeutic strategies for CF. A record of this paper's transparent peer review process is included in the supplemental information.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Proteomics Platform, Max Delbrück Center for Molecular Medicine, Berlin, Germany; Institute for Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany.
- Proteomics Platform, Max Delbrück Center for Molecular Medicine, Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
- Proteomics Platform, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
- Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine and Cystic Fibrosis Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität…
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine and Cystic Fibrosis Center, Charité - Universitäts…
- Division of Pediatric Pulmonology & Allergy and Cystic Fibrosis Center, Department of Pediatrics, University of Heidelberg, Heidelberg, Germany; Translational Lung Research Center Heidelberg (TLRC), German Center for Lu…
Förderung
- German Research Foundation
- Federal Ministry of Education and Research Bonn Office
Zitieren
APA
Fentker, K., Kirchner, M., Ziehm, M., Niquet, S., Popp, O., Duerr, J., Schaupp, L., Roehmel, J., Thee, S., Hämmerling, S., Sommerburg, O., Stahl, M., Graeber, S. Y., Mall, M. A., & Mertins, P. (2026). Systemic effects of cystic fibrosis transmembrane conductance regulator modulators on the plasma and serum proteome. Cell Systems. https://doi.org/10.1016/j.cels.2026.101569
Vancouver
Fentker K, Kirchner M, Ziehm M, Niquet S, Popp O, Duerr J, et al. Systemic effects of cystic fibrosis transmembrane conductance regulator modulators on the plasma and serum proteome. Cell Systems. 2026. doi:10.1016/j.cels.2026.101569
BibTeX
@article{Fentker2026,
author = {Fentker, Kerstin and Kirchner, Marieluise and Ziehm, Matthias and Niquet, Sylvia and Popp, Oliver and Duerr, Julia and Schaupp, Laura and Roehmel, Jobst and Thee, Stephanie and Hämmerling, Susanne and Sommerburg, Olaf and Stahl, Mirjam and Graeber, Simon Y and Mall, Marcus A and Mertins, Philipp},
title = {Systemic effects of cystic fibrosis transmembrane conductance regulator modulators on the plasma and serum proteome},
journal = {Cell Systems},
year = {2026},
doi = {10.1016/j.cels.2026.101569}
}
EUVIMED